J-Plasma (Renuvion): skin tightening after liposuction explained

Short answer: J-Plasma, marketed for aesthetic use as Renuvion, is a device that turns helium gas into plasma using radiofrequency (RF) energy. It is usually applied under the skin at the end of liposuction, in the same session and through the same small incisions, with the aim of helping mildly to moderately loose skin settle better onto the new contour. In the US, the FDA cleared its use in the tissue under the skin after liposuction for aesthetic body contouring on 27 April 2023. At Doctor G, J-Plasma is used in suitable patients, after an assessment of skin quality, in the same session as liposuction. It cannot remove excess skin; where there is significant excess, a skin-removing operation such as a tummy tuck is needed.

What exactly is J-Plasma / Renuvion?

J-Plasma and Renuvion are names from the same technology family made by Apyx Medical. J-Plasma is the surgical system that has long been used in operating rooms for cutting tissue and controlling bleeding; Renuvion is the brand name used for aesthetic applications. The principle is straightforward: helium gas flowing through a thin tip is ionised by RF energy and becomes plasma. That plasma delivers very brief, controlled heat to the tissue, with the aim of limiting how far the heat spreads into surrounding areas.

For body contouring the device is used beneath the skin rather than on its surface. After fat has been removed with liposuction, a thin handpiece is passed through the same entry points and the underside of the skin and the web of connective tissue between skin and muscle are heated. The idea is that these tissues contract so the skin drapes more evenly over the thinner fat layer. In a published series of 180 patients, the most commonly treated areas were the abdomen, thighs and arms, and 75% of patients also had VASER liposuction in the same session.

What it aims to do, and what it cannot do

Liposuction reduces fat but does not actively tighten skin. Skin with good elasticity retracts on its own once the fat is gone. Skin with borderline elasticity, however, may be left slightly loose. That is exactly the group J-Plasma is aimed at: patients who do not have true excess skin but whose ability to bounce back is uncertain.

• What it aims to do: help mildly to moderately lax skin retract better after liposuction; improve the appearance of loose skin in the neck and under the chin.
• What it cannot do: remove excess skin, correct an overhanging fold of skin that appears when you bend forward, repair separated abdominal muscles (diastasis recti), or remove stretch marks below the navel.

The American Society of Plastic Surgeons (ASPS) makes the same general point: skin can only contract so much, and where there is excess it may need to be surgically removed. That is when an excisional operation such as a tummy tuck, or an arm lift for the upper arms, comes into the conversation.

J-Plasma at Doctor G

Op. Dr. Göktuğ Esmer performs J-Plasma (Renuvion) in suitable patients in the same session as liposuction, VASER liposuction or 360 liposuction. The device is applied under the skin through the same small entry points used to remove the fat, so no additional incisions are needed and recovery follows the liposuction timeline.

Whether J-Plasma is used is decided after an assessment of your skin quality. This starts at an in-person examination or, for patients abroad, with photos and an online consultation; the final plan is confirmed at the examination in Istanbul. Skin elasticity, stretch marks, the amount of excess skin and how long your weight has been stable are all considered together. Where there is significant excess skin, a skin-removing operation is discussed instead of, or in addition to, J-Plasma.

FDA clearances

In the US, the device has received FDA 510(k) clearances for different uses step by step. Here is a plain timeline:

A 510(k) clearance means the FDA found the device substantially equivalent to a similar device already on the market and that it may be marketed for the stated use. Body use is described in general terms as "following liposuction" rather than by naming individual areas; in practice the abdomen, thighs and arms are the most commonly treated. The FDA also advises providers to follow the manufacturer's instructions and training and to tell patients which device will be used.

What do the studies show?

The key published studies on the device are:

• Neck and under-chin trial (Ruff, 2023): the study behind the FDA clearance found improvement in 82.5% of patients at day 180 on blinded photo review, with no serious device-related adverse events reported.
• Randomised study after massive weight loss (Barone, 2025): in 76 patients having a lipoabdominoplasty, the group that also received Renuvion had better BODY-Q skin scores at 6 months, 1 year and 2 years. In this study the device was used in addition to skin-removing surgery.
• Meta-analysis (Shridharani, 2026): pooling 34 studies and 3,508 patients, patient satisfaction was 92%. Because the studies used different methods, the results should be read in that context.

In practical terms, J-Plasma complements a liposuction plan. The foundation of the result is a well-planned liposuction, and the device is considered as part of that plan in patients whose skin quality suits it.

Possible side effects

As with any surgical procedure, J-Plasma has possible side effects. Most are similar to those after liposuction and are temporary:

• Temporary swelling and bruising
• Numbness or altered sensation in the treated area
• Fluid collecting under the skin (seroma), which sometimes needs draining with a needle
• Rarely, burns or changes in skin colour

These risks are minimised by the surgeon's training with the device, careful patient selection, following the manufacturer's protocol and keeping to your follow-up appointments. Your individual risks are discussed in detail at your consultation.

Who might benefit, and who needs something else?

• May be considered: patients planning liposuction who are at a stable weight and have mild to moderate laxity without an overhanging fold of skin; people with mild looseness in the neck and under the chin.
• Usually not enough: significant excess skin, an "apron" of skin that hangs when you lean forward, dense stretch marks below the navel, diastasis recti, or folds of skin after massive weight loss.

The line between "mild to moderate" and "significant" is not a formal criterion; it is a clinical judgement made at examination. We explain how this decision is made for the abdomen in our article on tummy tuck vs liposuction.

Questions to ask your surgeon

• Which device and which brand will be used?
• What training and hands-on experience does the surgeon have with this device?
• Which areas would it be used on, and why?
• What result would you expect without the device, and what could it realistically add?
• How are follow-up appointments planned after surgery?
• If I have excess skin, would a skin-removing operation suit me better?

How and when do results develop?

The first weeks look much like any liposuction recovery: swelling, bruising and a compression garment. Tissue contraction and healing take time, and in the studies results were usually assessed at around six months. Because there is no reliable data on swelling specific to J-Plasma, garment wear and check-up timing follow your surgeon's protocol. For the general picture, see our articles on compression garments after liposuction and when liposuction results appear.

If you are travelling from abroad, our international patients page covers planning and length of stay. To find out which approach suits your skin quality, you can arrange an examination with Op. Dr. Göktuğ Esmer through our contact page.